MAPT and tauopathy: On the basis of these findings, several therapeutic approaches for treating neurodegenerative tauopathies have been proposed, such as, kinase inhibitors [11], microtubule stabilizer [12], tau aggregation inhibitor [13], immunotherapy [14] and chaperone-based drugs targeting disease-specific tau species [15].